loading
Pliant Therapeutics Inc stock is traded at $1.57, with a volume of 378.36K. It is down -4.85% in the last 24 hours and up +7.53% over the past month. Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
See More
Previous Close:
$1.65
Open:
$1.65
24h Volume:
378.36K
Relative Volume:
0.47
Market Cap:
$96.38M
Revenue:
$5.03M
Net Income/Loss:
$-185.41M
P/E Ratio:
-0.5081
EPS:
-3.09
Net Cash Flow:
$-139.79M
1W Performance:
+6.80%
1M Performance:
+7.53%
6M Performance:
+7.53%
1Y Performance:
-89.30%
1-Day Range:
Value
$1.55
$1.699
1-Week Range:
Value
$1.46
$1.70
52-Week Range:
Value
$1.1001
$16.10

Pliant Therapeutics Inc Stock (PLRX) Company Profile

Name
Name
Pliant Therapeutics Inc
Name
Phone
650-481-6770
Name
Address
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA
Name
Employee
171
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
PLRX's Discussions on Twitter

Compare PLRX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
PLRX
Pliant Therapeutics Inc
1.57 101.29M 5.03M -185.41M -139.79M -3.09
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
416.81 104.76B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
481.67 63.06B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
578.05 60.32B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
843.66 51.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.76 34.49B 398.11M -1.03B -868.57M -5.7032

Pliant Therapeutics Inc Stock (PLRX) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-10-25 Downgrade JP Morgan Neutral → Underweight
Mar-04-25 Resumed Cantor Fitzgerald Neutral
Mar-04-25 Downgrade Needham Buy → Hold
Mar-03-25 Downgrade Leerink Partners Outperform → Market Perform
Mar-03-25 Downgrade Stifel Buy → Hold
Feb-10-25 Downgrade Canaccord Genuity Buy → Hold
Feb-10-25 Downgrade Citigroup Buy → Neutral
Feb-10-25 Downgrade H.C. Wainwright Buy → Neutral
Feb-10-25 Downgrade JP Morgan Overweight → Neutral
Feb-10-25 Downgrade Oppenheimer Outperform → Perform
Feb-10-25 Downgrade RBC Capital Mkts Outperform → Sector Perform
Feb-10-25 Downgrade Wells Fargo Overweight → Equal Weight
Sep-09-24 Resumed Leerink Partners Outperform
Dec-08-23 Initiated Wells Fargo Overweight
May-18-23 Initiated Canaccord Genuity Buy
Apr-13-23 Initiated Robert W. Baird Outperform
Dec-14-22 Initiated Stifel Buy
Dec-07-22 Initiated JP Morgan Overweight
Sep-01-22 Initiated Citigroup Buy
Jul-20-22 Initiated SVB Leerink Outperform
May-25-22 Initiated Cantor Fitzgerald Overweight
Dec-10-21 Initiated Oppenheimer Outperform
Nov-24-21 Initiated RBC Capital Mkts Outperform
Nov-03-21 Initiated H.C. Wainwright Buy
Apr-20-21 Initiated BTIG Research Buy
Apr-05-21 Initiated Citigroup Buy
Jun-29-20 Initiated Citigroup Buy
Jun-29-20 Initiated Cowen Outperform
Jun-29-20 Initiated Needham Buy
Jun-29-20 Initiated Piper Sandler Overweight
View All

Pliant Therapeutics Inc Stock (PLRX) Latest News

pulisher
12:24 PM

Evaluating Pliant Therapeutics Inc. with trendline analysisJuly 2025 Decliners & Fast Entry Momentum Alerts - newser.com

12:24 PM
pulisher
Oct 17, 2025

Technical signs of recovery in Pliant Therapeutics Inc.Share Buyback & Verified Entry Point Detection - newser.com

Oct 17, 2025
pulisher
Oct 17, 2025

Will Pliant Therapeutics Inc. stock gain from strong economyJuly 2025 Price Swings & Weekly Stock Breakout Alerts - Trung tâm Dự báo KTTV quốc gia

Oct 17, 2025
pulisher
Oct 17, 2025

Is Pliant Therapeutics Inc. stock oversold or undervaluedQuarterly Portfolio Review & Smart Money Movement Alerts - Trung tâm Dự báo KTTV quốc gia

Oct 17, 2025
pulisher
Oct 17, 2025

Will Pliant Therapeutics Inc. (9PT) stock keep raising dividends2025 Investor Takeaways & Low Drawdown Momentum Trade Ideas - Trung tâm Dự báo KTTV quốc gia

Oct 17, 2025
pulisher
Oct 17, 2025

How Pliant Therapeutics Inc. stock performs in weak economyEarnings Risk Report & Risk Managed Trade Strategies - Trung tâm Dự báo KTTV quốc gia

Oct 17, 2025
pulisher
Oct 17, 2025

3 Promising Penny Stocks With Market Caps Under $500M - simplywall.st

Oct 17, 2025
pulisher
Oct 17, 2025

Is Pliant Therapeutics Inc a good long term investmentPortfolio Diversification Tips & Exceptional Profit Trading - earlytimes.in

Oct 17, 2025
pulisher
Oct 17, 2025

Heatmap analysis for Pliant Therapeutics Inc. and competitorsEntry Point & High Accuracy Trade Signal Alerts - newser.com

Oct 17, 2025
pulisher
Oct 15, 2025

Does Pliant Therapeutics Inc. stock trade at a discount to peers - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Has Pliant Therapeutics Inc. found a price floor2025 Trading Recap & Growth Oriented Trade Recommendations - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

What to expect from Pliant Therapeutics Inc. in the next 30 daysWeekly Market Outlook & Weekly High Return Stock Opportunities - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

How sustainable is Pliant Therapeutics Inc. stock dividend payoutJuly 2025 Earnings & Weekly Chart Analysis and Guides - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Pliant Therapeutics Inc. stock trend forecastJuly 2025 Big Picture & Weekly Market Pulse Updates - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

Price momentum metrics for Pliant Therapeutics Inc. explainedJuly 2025 Volume & Weekly Market Pulse Alerts - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

How Pliant Therapeutics Inc. (9PT) stock reacts to new regulationsJuly 2025 News Drivers & Risk Managed Investment Strategies - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Can Pliant Therapeutics Inc. stock maintain operating marginsJuly 2025 Action & Verified Swing Trading Watchlist - newser.com

Oct 14, 2025
pulisher
Oct 12, 2025

Will Pliant Therapeutics Inc. bounce back from current supportJuly 2025 PostEarnings & Community Consensus Trade Alerts - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Can you recover from losses in Pliant Therapeutics Inc.Volume Spike & Weekly Watchlist of Top Performers - newser.com

Oct 12, 2025
pulisher
Oct 11, 2025

What analysts say about Pliant Therapeutics Inc stockDividend Cut Warnings & Low Risk Investment Plans - earlytimes.in

Oct 11, 2025
pulisher
Oct 11, 2025

Pliant Therapeutics' (PLRX) Underweight Rating Reiterated at JPMorgan Chase & Co. - MarketBeat

Oct 11, 2025
pulisher
Oct 10, 2025

JPMorgan downgrades Pliant Therapeutics stock rating to Underweight from Neutral - Investing.com Canada

Oct 10, 2025
pulisher
Oct 10, 2025

Pliant Therapeutics Shares Fall After JPMorgan Downgrade - MarketScreener

Oct 10, 2025
pulisher
Oct 10, 2025

Pliant Therapeutics Inc. stock outlook for YEARMarket Growth Review & Capital Protection Trade Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Allogene, Pliant down as J.P. Morgan cuts to Underweight on uncertain outlook - Seeking Alpha

Oct 10, 2025
pulisher
Oct 10, 2025

JPMorgan Downgrades Pliant Therapeutics to Underweight From Neutral - MarketScreener

Oct 10, 2025
pulisher
Oct 10, 2025

PLRX Downgraded by JP Morgan: Today's Key Analyst Rating Update - GuruFocus

Oct 10, 2025
pulisher
Oct 10, 2025

Order flow analysis tools used on Pliant Therapeutics Inc.July 2025 Intraday Action & Community Consensus Stock Picks - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Pliant Therapeutics (NASDAQ:PLRX) Receives "Sell (E+)" Rating from Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 09, 2025

Is Pliant Therapeutics Inc. (9PT) stock testing key supportPortfolio Growth Summary & Accurate Buy Signal Notifications - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Is Pliant Therapeutics Inc. (9PT) stock a top pick for value investorsGlobal Markets & Free Reliable Trade Execution Plans - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Detecting price anomalies in Pliant Therapeutics Inc. with AIJuly 2025 Big Picture & AI Powered Buy/Sell Recommendations - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

Why Pliant Therapeutics Inc. (9PT) stock attracts wealthy investorsJuly 2025 PostEarnings & Reliable Price Breakout Alerts - newser.com

Oct 06, 2025

Pliant Therapeutics Inc Stock (PLRX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Cap:     |  Volume (24h):